Biophytis S.A. (BPTS) Stock Analysis

What Biophytis S.A. does

Biophytis S.A. operates as a clinical-stage biotechnology firm dedicated to advancing therapeutic solutions aimed at decelerating degenerative processes and enhancing functional outcomes for individuals grappling with age-related illnesses. These therapies function by targeting and stimulating critical biological resilience pathways, which are designed to offer protection against and counteract the detrimental effects of various biological and environmental stressors contributing to age-associated pathologies. The company's flagship pharmaceutical candidate is Sarconeos (BIO101), an orally administered small molecule currently under development for addressing a spectrum of neuromuscular conditions, notably sarcopenia and Duchenne muscular dystrophy (DMD). Additionally, it is progressing through a Phase 2/3 clinical study to treat severe respiratory compromise in patients afflicted with COVID-19. Biophytis is also developing Macuneos (BIO201), another oral small molecule intended for ophthalmic disorders such as dry age-related macular degeneration (AMD) and Stargardt disease. In a collaborative effort, Biophytis SA has partnered with AFM-Telethon specifically for the advancement of Sarconeos (BIO101) in the context of DMD treatment. Established in 2006, the company maintains its corporate headquarters in Paris, France.

Key metrics

ETFs linked to BPTS

Broad-market and Healthcare sector ETFs an investor holding Biophytis S.A. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BPTS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Biophytis S.A.?

Biophytis S.A. trades under the ticker BPTS on NASDAQ.

Which exchange is BPTS listed on?

BPTS is listed on NASDAQ.

What sector does Biophytis S.A. operate in?

Biophytis S.A. is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BPTS in a portfolio?

PortView shows BPTS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.